270 related articles for article (PubMed ID: 17110443)
1. Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer.
Salido EC; Li XM; Lu Y; Wang X; Santana A; Roy-Chowdhury N; Torres A; Shapiro LJ; Roy-Chowdhury J
Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18249-54. PubMed ID: 17110443
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of liver and kidney proteins in a mouse model for primary hyperoxaluria type I.
Hernández-Fernaud JR; Salido E
FEBS J; 2010 Nov; 277(22):4766-74. PubMed ID: 20977670
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic correction of a mouse model for primary hyperoxaluria with adeno-associated virus gene transfer.
Salido E; Rodriguez-Pena M; Santana A; Beattie SG; Petry H; Torres A
Mol Ther; 2011 May; 19(5):870-5. PubMed ID: 21119625
[TBL] [Abstract][Full Text] [Related]
4. Generation of a Primary Hyperoxaluria Type 1 Disease Model Via CRISPR/Cas9 System in Rats.
Zheng R; Fang X; He L; Shao Y; Guo N; Wang L; Liu M; Li D; Geng H
Curr Mol Med; 2018; 18(7):436-447. PubMed ID: 30539697
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterization of a novel rat model of primary hyperoxaluria type 1 with a nonsense mutation in alanine-glyoxylate aminotransferase gene.
Li Y; Zheng R; Xu G; Huang Y; Li Y; Li D; Geng H
Am J Physiol Renal Physiol; 2021 Mar; 320(3):F475-F484. PubMed ID: 33491567
[TBL] [Abstract][Full Text] [Related]
6. Systemic Alanine Glyoxylate Aminotransferase mRNA Improves Glyoxylate Metabolism in a Mouse Model of Primary Hyperoxaluria Type 1.
Kukreja A; Lasaro M; Cobaugh C; Forbes C; Tang JP; Gao X; Martin-Higueras C; Pey AL; Salido E; Sobolov S; Subramanian RR
Nucleic Acid Ther; 2019 Apr; 29(2):104-113. PubMed ID: 30676254
[TBL] [Abstract][Full Text] [Related]
7. Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter.
Hatch M; Gjymishka A; Salido EC; Allison MJ; Freel RW
Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G461-9. PubMed ID: 21163900
[TBL] [Abstract][Full Text] [Related]
8. Effect of alanine supplementation on oxalate synthesis.
Wood KD; Freeman BL; Killian ME; Lai WS; Assimos D; Knight J; Fargue S
Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165981. PubMed ID: 33002578
[TBL] [Abstract][Full Text] [Related]
9. Correction of hyperoxaluria by liver repopulation with hepatocytes in a mouse model of primary hyperoxaluria type-1.
Jiang J; Salido EC; Guha C; Wang X; Moitra R; Liu L; Roy-Chowdhury J; Roy-Chowdhury N
Transplantation; 2008 May; 85(9):1253-60. PubMed ID: 18475180
[TBL] [Abstract][Full Text] [Related]
10. Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene.
Williams EL; Acquaviva C; Amoroso A; Chevalier F; Coulter-Mackie M; Monico CG; Giachino D; Owen T; Robbiano A; Salido E; Waterham H; Rumsby G
Hum Mutat; 2009 Jun; 30(6):910-7. PubMed ID: 19479957
[TBL] [Abstract][Full Text] [Related]
11. [From gene to disease; primary hyperoxaluria type I caused by mutations in the AGXT gene].
van Woerden CS; Groothof JW; Wanders RJ; Waterham HR; Wijburg FR
Ned Tijdschr Geneeskd; 2006 Jul; 150(30):1669-72. PubMed ID: 16922352
[TBL] [Abstract][Full Text] [Related]
12. A Putative Mutation Hotspot of the AGXT Gene Associated with Primary Hyperoxaluria Type 1 in the Chinese Population.
Li X; Gu J; Yang Y; Li J; Li Y
Tohoku J Exp Med; 2018 Dec; 246(4):233-241. PubMed ID: 30541997
[TBL] [Abstract][Full Text] [Related]
13. Primary hyperoxaluria type 1 in the Canary Islands: a conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase.
Santana A; Salido E; Torres A; Shapiro LJ
Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7277-82. PubMed ID: 12777626
[TBL] [Abstract][Full Text] [Related]
14. Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase.
Oppici E; Roncador A; Montioli R; Bianconi S; Cellini B
Biochim Biophys Acta; 2013 Dec; 1832(12):2277-88. PubMed ID: 24055001
[TBL] [Abstract][Full Text] [Related]
15. Molecular aetiology of primary hyperoxaluria type 1.
Danpure CJ
Nephron Exp Nephrol; 2004; 98(2):e39-44. PubMed ID: 15499210
[TBL] [Abstract][Full Text] [Related]
16. Mutation spectrum of primary hyperoxaluria type 1 in Tunisia: implication for diagnosis in North Africa.
Nagara M; Tiar A; Ben Halim N; Ben Rhouma F; Messaoud O; Bouyacoub Y; Kefi R; Hassayoun S; Zouari N; Ben Ammar MS; Abdelhak S; Chemli J
Gene; 2013 Sep; 527(1):316-20. PubMed ID: 23810941
[TBL] [Abstract][Full Text] [Related]
17. Primary hyperoxalurias: disorders of glyoxylate detoxification.
Salido E; Pey AL; Rodriguez R; Lorenzo V
Biochim Biophys Acta; 2012 Sep; 1822(9):1453-64. PubMed ID: 22446032
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9-mediated metabolic pathway reprogramming in a novel humanized rat model ameliorates primary hyperoxaluria type 1.
Zheng R; Li Y; Wang L; Fang X; Zhang J; He L; Yang L; Li D; Geng H
Kidney Int; 2020 Oct; 98(4):947-957. PubMed ID: 32464217
[TBL] [Abstract][Full Text] [Related]
19. Identification of compound heterozygous patients with primary hyperoxaluria type 1: clinical evaluations and in silico investigations.
Kanoun H; Jarraya F; Maalej B; Lahiani A; Mahfoudh H; Makni F; Hachicha J; Fakhfakh F
BMC Nephrol; 2017 Oct; 18(1):303. PubMed ID: 28969594
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel AGXT gene mutation in primary hyperoxaluria after kidney transplantation failure.
M'dimegh S; Omezzine A; Hamida-Rebai MB; Aquaviva-Bourdain C; M'barek I; Sahtout W; Zellama D; Souche G; Achour A; Abroug S; Bouslama A
Transpl Immunol; 2016 Nov; 39():60-65. PubMed ID: 27568336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
